Meek David D.
CIK 0001555337
Chief Executive OfficerDirector
Filings
18
Latest Jun 24, 2025
Issuers covered
5
Showing
18 of 18
Page 1
Track record
5 of 6 open-market trades scored (83% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 40% | -6.4% | -2.0% | +45.2% | -73.5% |
| 90 days | 5 | 60% | +15.3% | +8.4% | +60.6% | -4.2% |
| 180 days | 5 | 40% | -30.1% | -15.2% | +60.2% | -191.4% |
| 365 days | 4 | 50% | -18.0% | +22.2% | +75.9% | -192.2% |
Issuers
Companies where Meek David D. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| QURE | Uniqure N.V. | 9 | Jun 24, 2025 |
| MRTX | Mirati Therapeutics, Inc. | 3 | Jan 24, 2023 |
| CGEM | Cullinan Oncology, Inc. | 2 | Jun 16, 2025 |
| ETTX | Entasis Therapeutics Holdings Inc. | 2 | Feb 15, 2022 |
| FUSN | Fusion Pharmaceuticals Inc. | 2 | Jun 4, 2024 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|